Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renoprotective Effects of Dexmedetomidine Pharmacological Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: A Randomized Controlled Trial

NCT07841054 is registered in ClinicalTrials.gov with Bursa City Hospital as lead sponsor.

NCT NCT07841054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07841054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renoprotective Effects of Dexmedetomidine Pharmacological Preconditioning in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: A Randomized Controlled Trial
Lead sponsor
Bursa City Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 20, 2025
Completion date
August 1, 2026
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiopulmonary bypass graft, dexmedetomidine, postoperative acute kidney injury, postoperative complications